Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model
Michaela R. Reagan, Yuji Mishima, Siobhan Glavey, Yong Zhang, Salomon Manier, Zhi Ning Lu, Masoumeh Memarzadeh, Yu Zhang, Antonio Sacco, Yosra Aljawai, Jiantao Shi, Yu‐Tzu Tai, John E. Ready, David Kaplan, Aldo M. Roccaro, Irene M. Ghobrial (2014). Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model. , 124(22), DOI: https://doi.org/10.1182/blood-2014-02-558007.
Article34 days agoMicrorna-Dependent Modulation Of Osteogenesis In a 3D In Vitro Bone Marrow Model System Of Multiple Myeloma
Michaela R. Reagan, Yuji Mishima, Yong Zhang, Patricia Maiso, Salomon Manier, Yu‐Tzu Tai, Priya Dhir, Zhi Ning Lu, Masoumeh Memarzadeh, Antonio Sacco, Yosra Aljawai, Susanna Santos, John E. Ready, David Kaplan, Aldo M. Roccaro, Irene M. Ghobrial (2013). Microrna-Dependent Modulation Of Osteogenesis In a 3D In Vitro Bone Marrow Model System Of Multiple Myeloma. , 122(21), DOI: https://doi.org/10.1182/blood.v122.21.3093.3093.
Article34 days agoMultiple Myeloma-Derived Bone-Marrow Mesenchymal Stem Cells: Microrna-, Gene Expression-Profiling and Functional Characterization
Michaela R. Reagan, Aldo M. Roccaro, Abdelkareem Azab, Yong Zhang, Grace B O'Callaghan, Patricia Maiso, Salomon Manier, David Kaplan, Irene M. Ghobrial (2012). Multiple Myeloma-Derived Bone-Marrow Mesenchymal Stem Cells: Microrna-, Gene Expression-Profiling and Functional Characterization. , 120(21), DOI: https://doi.org/10.1182/blood.v120.21.1837.1837.
Article34 days agoLinvoseltamab (LINVO) + bortezomib (BTZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): First results from the LINKER-MM2 trial.
Paula Rodríguez‐Otero, Sosana Delimpasi, Albert Oriol, Meletios A Dimopoulos, Xavier P. Leleu, Salomon Manier, Carmen Martínez‐Chamorro, Rajshekhar Chakraborty, Sam Rubinstein, Anna Sureda, Marta Sonia González, Jean‐Marie Michot, Aurora Breazna, James Drew, Anita Boyapati, Sheila Masinde, Glenn S. Kroog, Shawn Sarkaria, Joaquín Martínez‐López (2025). Linvoseltamab (LINVO) + bortezomib (BTZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): First results from the LINKER-MM2 trial.. , 43(16_suppl), DOI: https://doi.org/10.1200/jco.2025.43.16_suppl.7510.
Article33 days agoSequencing BCMA‐ and GPRC5D‐targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network
Niels W.C.J. van de Donk, Philippe Moreau, Jesús F. San Miguel, María‐Victoria Mateos, Meletios A Dimopoulos, Sonja Zweegman, Francesca Gay, Monika Engelhardt, Roberto Mina, Elena Zamagni, Michel Delforge, Meral Beksaç, Andrew Spencer, Fredrik Schjesvold, Christoph Driessen, Martin Kaiser, Aurore Perrot, Ralph Wäsch, Charlotte L.B.M. Korst, Annemiek Broijl, Cyrille Touzeau, Salomon Manier, Roman Hájek, Jelena Bila, Güldane Cengiz Seval, Michael O’Dwyer, Heinz Ludwig, Carlos Fernández de Larrea, Rakesh Popat, Pellegrino Musto, Paula Rodríguez‐Otero, Kwee Yong, K. Martin Kortüm, Leo Rasche, Evangelos Terpos, Marc S. Raab, Mario Boccadoro, Pieter Sonneveld, Hermann Einsele (2025). Sequencing BCMA‐ and GPRC5D‐targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma Network. , 9(11), DOI: https://doi.org/10.1002/hem3.70260.
Article33 days ago